What is known is that some of these gene products were shown to be implicated in prostate cancer progression, such as, for example, SLC7A5 [59], SLC7A11 [60], SLC11A1 [61], SLC43A1 [62] and SLC1A3 [63]. This evidence concerns the gene SLC7A5 and prostate cancer.